Daivobet 50 mcg/g + 0,5 mg/g ointment Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

daivobet 50 mcg/g + 0,5 mg/g ointment

leo pharma a/s - Бетаметазон, Кальципотриол - 50 mcg/g + 0,5 mg/g ointment

Fucidin H 20 mg/10 mg/ g cream Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

fucidin h 20 mg/10 mg/ g cream

leo pharma a/s - Хидрокортизон и антибиотици - 20 mg/10 mg/ g cream

Xamiol 50 micrograms/0,5 mg/g gel Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

xamiol 50 micrograms/0,5 mg/g gel

leo pharma a/s - 50 micrograms/0,5 mg/g gel

Daivobet 50 mcg/g + 0,5 mg/g gel Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

daivobet 50 mcg/g + 0,5 mg/g gel

leo pharma a/s - 50 mcg/g + 0,5 mg/g gel

Oleovit D3 14 400 IU/ml oral drops, Solution Bulgaria - bulgarsk - Изпълнителна агенция по лекарствата

oleovit d3 14 400 iu/ml oral drops, solution

14 400 iu/ml oral drops, solution

Mvabea Den europeiske union - bulgarsk - EMA (European Medicines Agency)

mvabea

janssen-cilag international n.v.    - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - Хеморагична Треска Ебола - Ваксини - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.

Besremi Den europeiske union - bulgarsk - EMA (European Medicines Agency)

besremi

aop orphan pharmaceuticals gmbh - ropeginterferon алфа-2b - Истинска Полицитемия - Иммуностимуляторы, - besremi включен като монотерапии при възрастни за лечение на полицитемия вера, без симптоматично спленомегалии.

Sugammadex Amomed Den europeiske union - bulgarsk - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - Невромускулна блокада - Всички други терапевтични продукти - Възстановяване на нервно-мускулната блокада, предизвикана от рокурония или векурония. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Abecma Den europeiske union - bulgarsk - EMA (European Medicines Agency)

abecma

bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - Антинеопластични средства - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.

Zinforo Den europeiske union - bulgarsk - EMA (European Medicines Agency)

zinforo

pfizer ireland pharmaceuticals - fosamil цефтаролин - community-acquired infections; skin diseases, infectious; pneumonia - Антибактериални средства за подаване на заявления, - zinforo is indicated for the treatment of the following infections in neonates, infants, children, adolescents and adults: , complicated skin and soft tissue infections (cssti), community-acquired pneumonia (cap) , consideration should be given to official guidance on the appropriate use of antibacterial agents.